Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Feasibility Study of Autologous Stromal Vascular Fraction (SVF) Cells for Treatment of Osteoarthritis

NCT01885832 is registered in ClinicalTrials.gov with Translational Biosciences as lead sponsor.

NCT NCT01885832
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01885832 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Feasibility Study of Autologous Stromal Vascular Fraction (SVF) Cells for Treatment of Osteoarthritis
Lead sponsor
Translational Biosciences
Phase
Phase 1/2
Overall status
Withdrawn
Start date
June 30, 2013
Completion date
December 31, 2016
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

osteoarthritis